• Isochlorogenic Acid A Hydrogel for Wound Repair

  2026-09-01

  A 2026 study developed an amylopectin/carboxymethyl chitosan hydrogel containing Isochlorogenic acid A/Fe(III) co-assembled nanoparticles to address the compound’s solubility and stability constraints in infected wound repair. The composite combined antibacterial activity, favorable physical properties, enhanced cell migration, and improved healing-associated inflammatory and vascularization markers in vitro and in vivo.

• How ARBs Reprogram Cold Tumors for Checkpoint Therapy

  2026-08-31

  The reference study identifies AGTR1 as a stromal vulnerability in collagen-rich, immune-excluded “armored and cold” tumors and shows that angiotensin receptor blockade can improve immune checkpoint blockade responses. Its key contribution is linking AT1-axis inhibition in cancer-associated fibroblasts to reduced collagen production, tumor-microenvironment remodeling, and clinical response patterns across cohorts.

• Mycophenolic acid: Reliable Cell Assay Design

  2026-08-31

  Learn how Mycophenolic acid, SKU B1981, can improve the interpretation and reproducibility of cell viability, proliferation, and immunometabolism assays. This scenario-based guide covers solvent handling, protocol optimization, data interpretation, and practical vendor selection.

• Pentoxifylline Workflows for Inflammation Research

  2026-08-30

  Pentoxifylline combines phosphodiesterase inhibition with practical utility across LPS-driven inflammation, neonatal sepsis models, psoriasis research, and sperm-motility assays. This workflow-focused guide covers concentration selection, TLR4-centered readouts, cross-domain applications, and troubleshooting for more reproducible experiments.

• Deracoxib in COX-2 Inflammation Assays

  2026-08-29

  Deracoxib is a selective COX-2 inhibitor that can help separate prostaglandin-driven effects from broader inflammatory signaling. This guide builds an assay strategy around orthogonal readouts, viability controls, and insights from a poly(I:C)-macrophage study.

• NEDD4L–PRMT5 Axis in Colorectal Cancer Metastasis

  2026-08-28

  The reference study identifies NEDD4L as an E3 ubiquitin ligase that suppresses colorectal cancer liver metastasis by targeting PRMT5 for degradation. Its in vivo screening strategy connects a defined ubiquitin-regulatory event to reduced AKT1 arginine methylation, AKT/mTOR signaling, tumor-cell proliferation, and metastatic colonization.

• XAV-939 Workflows for Wnt and Cardiac Research

  2026-08-28

  XAV-939 provides reversible tankyrase 1 and 2 inhibition for dissecting axin-dependent Wnt/β-catenin biology across cancer, fibrosis, stem-cell differentiation, and exploratory cardiac models. This workflow connects pathway pharmacology with the ATRNL1-centered cell-state findings of a large human atrial fibrillation study while clearly separating established evidence from follow-up hypotheses.

• Pentoxifylline Downregulates ICAM-1 in Monocytes

  2026-08-27

  The reference study established that Pentoxifylline suppresses ICAM-1 expression in human monocytes after oral exposure and during direct cell treatment, with reductions detectable at both protein and mRNA levels. Its TNF-α add-back and neutralization experiments linked this effect to secondary suppression of TNF-α signaling, providing a mechanistic basis for studying this phosphodiesterase inhibitor as an anti-inflammatory and immunomodulatory agent.

• T0070907: PPARγ Antagonist Workflow Guide

  2026-08-27

  T0070907 is a high-affinity PPARγ antagonist for separating receptor-dependent transcription from downstream cellular effects. This guide shows how to apply it in reporter assays, adipogenesis models, macrophage inflammation studies, and cancer cell-cycle experiments while controlling for solubility, timing, and off-target interpretation.

• TMRE Mitochondrial Membrane Potential Assay Kit Guide

  2026-08-26

  Learn how to use TMRE fluorescence to quantify mitochondrial depolarization in apoptosis, sodium-overload models, isolated mitochondria, and high-throughput screens. This practical guide combines assay setup, controls, optimization ranges, and troubleshooting with mechanistic insights from recent NECSO research.

• 2-D08 and the Translational Logic of SUMO Biology

  2026-08-26

  SUMO regulation is emerging as a context-dependent control point in cancer biology and tissue injury. This article connects 2-D08 mechanistic selectivity with new findings on the ETS1/SENP2/HSPA8/FUNDC1 axis in bronchopulmonary dysplasia, while defining practical boundaries for translational interpretation.

• Pterostilbene and Mitochondrial Quality in Dermal Aging

  2026-08-25

  Zhou et al. show that pterostilbene reduces senescence phenotypes in human dermal fibroblasts by improving mitochondrial quality and promoting mitophagy. The study connects mitochondrial structure, membrane potential, respiration, and extracellular-matrix maintenance, while also providing a preclinical basis for imaging and cytometric workflows in skin-aging research.

• Latrunculin B for Actin Dynamics Studies

  2026-08-25

  Latrunculin B provides a transient, cell-permeable way to test how actin filament assembly influences morphology, trafficking, and infection assays. This workflow emphasizes short pulses, fresh dosing, matched vehicle controls, and interpretation of negative results in pathway studies.

• Coelenterazine Workflows for ROS and Reporter Assays

  2026-08-24

  Coelenterazine links luciferase reporter measurements with chemiluminescent detection of superoxide anion and peroxynitrite. This practical guide covers solvent handling, AVP reporter workflows, BRET and high-throughput screening, cancer-associated ROS imaging, and troubleshooting strategies for cleaner, more reproducible data.

• T0070907 for Reliable PPARγ Assays

  2026-08-24

  Learn how T0070907 (SKU A4301) can clarify PPARγ-dependent effects in viability, adipogenesis, cancer-cell-cycle, and inflammatory assays. This scenario-based guide covers experimental controls, formulation, stock handling, interpretation limits, and practical vendor-selection criteria.

8063 records 5/538 page Previous Next 12345 下5页 Last page